Explain That Biosimilars are not Exact Generic Equivalents

October 2015

You may get questions about "biosimilars"...due to the launch of the FIRST biosimilar, Zarxio (zar-zee-oh, filgrastim-sndz).

Zarxio is a biosimilar for Neupogen. Expect to also see biosimilars for Epogen, Humira, and Remicade in the next few years.

Be ready to answer common questions about biosimilars.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote